A developer of cancer treatments triggered by tumor chemistry is partnering with biologic drug maker Regeneron on dual-action cancer immunotherapies. . . . → Read More: Biotech, Regeneron in $2B Cancer Antibody Deal
|
|||||
       |
 Comments are closed  Intellectual property, Joint ventures/collaborations, New products  biomedical, biotechnology, cancer, chemistry, licensing, life sciences, pharmaceuticals, physical sciences 
A start-up enterprise seeks to make drugs for treating rare diseases more readily available to physicians and patients in Europe. . . . → Read More: Company to Boost Orphan Drugs in Europe Comments are closed Intellectual property, New products, Regulations biomedical, economics, entrepreneurs, Europe, licensing, life sciences, pharmaceuticals 
Developers of a patch with tiny needles instead of a syringe to deliver vaccines say a clinical trial testing a Covid-19 patch is now underway in Australia. . . . → Read More: Covid-19 Vaccine Patch Clinical Trial Begins Comments are closed New products Australia, biomedical, biotechnology, chemistry, clinical trials, Covid-19, engineering, licensing, life sciences, medical device, pharmaceuticals, physical sciences, university 
A clinical trial is underway testing a synthetic antibody designed to prevent SARS-CoV-2 viral infections in people with compromised immune systems. . . . → Read More: Trial in Progress of Antibody Blocking Covid-19 in Immunocompromised Comments are closed New products biomedical, biotechnology, clinical trials, Covid-19, entrepreneurs, Europe, licensing, life sciences, pharmaceuticals 
A company making precision therapies for neurological disorders is acquiring rights to a compound first designed as a treatment for cancer, inflammation, and oxidative stress. . . . → Read More: Drug Licensed for Precision Autism Spectrum Therapies Comments are closed Intellectual property biomedical, biotechnology, chemistry, Europe, genomics, licensing, life sciences, mathematics, pharmaceuticals, physical sciences 
A biotechnology company developing gene-edited therapies for bacterial infections in the gut received a U.S. patent for viruses engineered as treatments. . . . → Read More: Patent Issued for Crispr-Edited Viruses in Microbiome 2 comments - (Comments are closed) Intellectual property biomedical, biotechnology, cancer, Europe, genomics, licensing, life sciences, patent, pharmaceuticals, university, USPTO 
A new company is acquiring a technology using genome-edited tadpoles that finds current drugs addressing precise genetic conditions underlying rare diseases. . . . → Read More: Start-Up Licenses Gene-Edited Drug Discovery Tech. One comment - (Comments are closed) Intellectual property, New products biomedical, biotechnology, engineering, entrepreneurs, genomics, licensing, life sciences, mathematics, pharmaceuticals, physical sciences, university 
A joint venture with business development and bio-manufacturing companies aims to build new cell and gene therapy businesses to advance treatments from Mayo Clinic labs. . . . → Read More: Venture to Build Cell, Gene Therapy Businesses One comment - (Comments are closed) Joint ventures/collaborations biomedical, biotechnology, China, entrepreneurs, genomics, investment, licensing, life sciences, manufacturing, pharmaceuticals, stem cells 
A genetic technology for synthesizing cannabinoid compounds without cannabis cells was licensed to a company spun-off from the lab that developed the process. . . . → Read More: Cannabinoid Synthesis Process Licensed to Spin-Off Company Comments are closed Intellectual property, New products biomedical, biotechnology, chemistry, entrepreneurs, genomics, Israel, licensing, life sciences, pharmaceuticals, physical sciences, university 
Two companies agreed to license technologies from academic labs in the U.S. and U.K. for developing faster and more sensitive at-home tests for Covid-19 infections. . . . → Read More: Univ. Labs Ink Licensing Deals for Covid-19 Tests Comments are closed Intellectual property, New products biomedical, biotechnology, chemistry, Covid-19, entrepreneurs, genomics, licensing, life sciences, medical device, physical sciences, U.K., university |
||||
|
Copyright © 2024 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
RSS - Posts